UCB U.S. News | UCB

UCB's Global Corporate Website

Welcome to UCB in the United States

Healthcare Professionals

Categories

Archives

2026
- March
- February
2025
- December
- November
- October
- September
- August
- July
- June
- May
- April
- March
- February
- January
2024
- December
- November
- October
- September
- August
- July
- June
- May
- April
- March
- February
- January
2023
- December
- November
- October
- September
- August
- July
- June
- April
- March
- February
- January
2022
- December
- November
- September
- August
- June
- May
- March
- February
- January
2021
- December
- November
- October
- September
- August
- May
- April
- February

Mar

28

FINTEPLA® (fenfluramine) Oral Solution Now FDA Approved for Treatment of Seizures Associated with Lennox-Gastaut Syndrome (LGS)

Read More

Mar

26

New Long-Term Complete Skin Clearance Data for Bimekizumab in Moderate to Severe Plaque Psoriasis Presented at the 2022 AAD Annual Meeting

Read More

Mar

07

UCB Completes Acquisition of Zogenix, Inc.

Read More

Choose a Country